A Comparative Analysis of Cytochrome P450 Activities in Paired Liver and Small Intestinal Samples from Patients with Obesity-Reference-Cited by-同舟云学术

A Comparative Analysis of Cytochrome P450 Activities in Paired Liver and Small Intestinal Samples from Patients with Obesity

Published:2019-11-04 Issue:1 Volume:48 Page:8-17
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Krogstad Veronica,Peric Alexandra^ORCID,Robertsen Ida,Kringen Marianne K.,Wegler Christine,Angeles Philip Carlo,Hjelmesæth Jøran,Karlsson Cecilia,Andersson Shalini,Artursson Per^ORCID,Åsberg Anders,Andersson Tommy B.,Christensen Hege

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference54 articles.

1. Expression of Hepatic Drug-Metabolizing Cytochrome P450 Enzymes and Their Intercorrelations: A Meta-Analysis

2. Gene-Specific Effects of Inflammatory Cytokines on Cytochrome P450 2C, 2B6 and 3A4 mRNA Levels in Human Hepatocytes

3. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines forCYP3A5Genotype and Tacrolimus Dosing

4. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

5. Impact of Obesity on Drug Metabolism and Elimination in Adults and Children

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of bariatric surgery on cytochrome P 450 enzyme activity;Frontiers in Pharmacology;2024-03-25

2. 9-HODE and 9-HOTrE alter mitochondrial metabolism, increase triglycerides, and perturb fatty acid uptake and synthesis associated gene expression in HepG2 cells;Prostaglandins, Leukotrienes and Essential Fatty Acids;2024-03

3. Pharmacokinetic Properties of CYP3A Substrate Midazolam Associated with Xenobiotic-Mediated CYP Induction in Inflammation Model Mice;BPB Reports;2024

4. Pharmacokinetics of obese adults: Not only an increase in weight;Biomedicine & Pharmacotherapy;2023-10

5. Neither Gastric Bypass Surgery Nor Diet-Induced Weight-Loss Affect OATP1B1 Activity as Measured by Rosuvastatin Oral Clearance;Clinical Pharmacokinetics;2023-03-29